| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 48.75B | 49.70B | 54.28B | 52.20B | 66.90B | 46.36B |
| Gross Profit | 7.87B | 5.20B | 5.63B | 6.16B | 11.36B | 5.74B |
| EBITDA | 11.45B | 10.38B | 9.56B | 10.23B | 13.90B | 6.66B |
| Net Income | 4.64B | 3.93B | 3.14B | 4.11B | 6.45B | 587.00M |
Balance Sheet | ||||||
| Total Assets | 64.85B | 63.42B | 56.54B | 53.91B | 55.87B | 54.10B |
| Cash, Cash Equivalents and Short-Term Investments | 2.58B | 2.74B | 3.09B | 2.23B | 4.52B | 2.87B |
| Total Debt | 13.75B | 14.21B | 10.63B | 9.95B | 11.64B | 15.42B |
| Total Liabilities | 32.31B | 31.79B | 26.77B | 25.20B | 28.28B | 30.50B |
| Stockholders Equity | 32.52B | 31.62B | 29.75B | 28.70B | 27.58B | 23.60B |
Cash Flow | ||||||
| Free Cash Flow | 4.36B | 3.41B | 4.22B | 3.09B | 7.64B | 3.36B |
| Operating Cash Flow | 9.09B | 8.23B | 9.23B | 7.39B | 11.40B | 5.92B |
| Investing Cash Flow | -7.40B | -7.68B | -5.13B | -5.29B | -2.31B | -942.00M |
| Financing Cash Flow | -1.79B | -749.00M | -3.50B | -4.31B | -7.68B | -2.51B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | C$66.38B | 14.35 | 15.23% | 3.40% | -10.01% | 67.09% | |
71 Outperform | C$76.97B | 24.61 | 13.38% | 2.45% | -7.49% | -37.07% | |
71 Outperform | C$37.91B | 22.41 | 9.98% | 5.44% | -5.92% | -12.92% | |
69 Neutral | C$92.31B | 14.69 | 14.01% | 3.91% | 0.86% | 8.90% | |
69 Neutral | C$95.80B | 28.99 | 12.53% | 4.41% | 1.37% | -24.17% | |
67 Neutral | C$23.36B | 32.93 | 4.40% | 4.79% | 7.06% | -45.27% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% |